DRKS00022767已完成不适用
Investigations on biomarker search in patients with non-small-cell bronchial carcinoma under checkpoint inhibitor therapy
Krankenhaus Martha-Maria Halle-Dölau0 个研究点目标入组 92 人开始时间: 2020年10月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 92
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients must be able to give consent themselves
- •- signed consent form
- •- histologically confirmed NSCLC with indication for palliative immunotherapy with or without chemotherapy
排除标准
- •- histologically confirmed SCLC
- •- previous immunotherapies
研究者
相似试验
已完成
不适用
Investigations on biomarker search in patients with bronchial carcinoma under antibody (checkpoint blockade) therapyC34.9Bronchus or lung, unspecifiedDRKS00022872Krankenhaus Martha-Maria Halle-Dölau30
招募中
不适用
Clinical research for biomarkers in patients with drug-induced lung injury and their clinical significanceCases of suspected drug-induced lung injury and performed bronchoalveolar lavage for diagnosticJPRN-UMIN000033951niversity of Occupational and Environmental Health, Department of Respiratory Medicine60
已完成
2 期
Biomarker discovery study to identify patients with advanced urothelial cancer benefitting from pembrolizumab treatmenturinary tract cancerurothelial carcinoma10038364NL-OMON53077Erasmus MC, Universitair Medisch Centrum Rotterdam80
进行中（未招募）
1 期
Biomarker discovery study to identify patients with advanced urothelial cancer benefitting from pembrolizumab treatmentEUCTR2017-000976-27-NLErasmus MC Cancer Institute80
尚未招募
不适用
Detection of prognostic biomarkers in patients with oral squamous cell carcinoma with tissue microarrayOral Squamous Cell CarcinomaC01C02C03C04C05C06Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthDRKS00010431niversitätsklinikum Hamburg-Eppendorf1,000